Vor Biopharma Inc. Common Stock

VOR XNAS • BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

740M

Short interest (May 15)

8.5%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.53%

↓ 1.2%

Available Shares

↑ 6.9%

Price Chart

Company Overview

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Company Info

Exchange: NASDAQ

Industry: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

CIK: 0001817229

Asset Type: CS

Market Data

Market Cap: $740,179,079

Employees: 76

Status: Active

Short Interest

Current Borrow Fee 0.53%

Range: 0.52% - 0.61%

Available Shares 1M

Range: 1M - 1M

Recent Changes

Fee Change: ↓ 4.2%

Available Change: ↓ 8.7%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime